Liver Transplantation Compared to Chemotherapy in Patients With ColoRectal Cancer

The trial is a randomized control trial. Patients are randomized between Ltx and other treatment that may include further chemotherapy, TACE, SIRT or other available treatment options. The patients will be randomized 1:1 to Ltx and chemotherapy/other treatment options.

Trial Details

NCT ID
NCT03494946
Phase
NA
Sponsor
Oslo University Hospital
Status
RECRUITING
Cancer Type
Liver Cancer
Interventions
  • Liver transplantation
  • Chemotherapy
Locations (sample)
  • Oslo, Norway|59.91273,10.74609

Key Eligibility Criteria

  • Histologically verified adenocarcinoma in colon/rectum.
  • Liver metastases, not amenable to liver resection
  • No signs of extra hepatic metastatic disease or local recurrence according to PET/CT scan within 6 weeks prior to the faculty meeting at the transp…
  • No signs of extra hepatic metastatic disease on CT or MRI thorax/abdomen/pelvis within 6 weeks prior to the faculty meeting at the transplant unit,…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Liver Cancer Trials on Trialify →